Keyphrases
Carcinoembryonic Antigen
100%
Long-term Survival
100%
Tumor Immunity
100%
Cyclooxygenase-2 Inhibitors
100%
Celecoxib
100%
Poxvirus
100%
Cyclooxygenase-2
50%
Gastrointestinal Neoplasms
40%
Supplemented Diets
30%
Transgenic
20%
Familial Adenomatous Polyposis
20%
Tumor Burden
20%
Knock-in Mouse Model
10%
Transgenic Mice
10%
Recombinant
10%
MRNA Level
10%
Overexpressing
10%
Natural Killer Cells
10%
Overexpression
10%
Overall Survival
10%
Host Immunity
10%
T Cells
10%
Antigen-specific
10%
Splenic T Cells
10%
Eosinophilia
10%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
10%
Neoplasia
10%
Concanavalin A (Con A)
10%
Host Immune Response
10%
Lipopolysaccharide
10%
Antitumor
10%
Chronic Administration
10%
Autoimmunity
10%
IFN Production
10%
Murine Tumor Model
10%
Prostaglandin E2
10%
Vaccination Protocols
10%
Celebrex
10%
Early Phase Clinical Trials
10%
Adenomatous Polyposis Coli
10%
Medicine and Dentistry
Long Term Survival
100%
Cyclooxygenase 2 Inhibitor
100%
Carcinoembryonic Antigen
100%
Celecoxib
100%
Poxviridae
100%
Neoplasm
60%
Cyclooxygenase 2
50%
Familial Adenomatous Polyposis
20%
Transgenic Mouse
10%
Recombinant
10%
Overall Survival
10%
Precancerous Condition
10%
Clinical Study
10%
Splenic T Cell
10%
T Cell
10%
Eosinophilia
10%
Nonsteroid Antiinflammatory Agent
10%
Natural Killer Cell
10%
Concanavalin A
10%
B Cell
10%
Immune Response
10%
Lipopolysaccharide
10%
Prostaglandin E2
10%
Breed
10%
Tumor Model
10%
Antigen Specificity
10%
Autoimmunity
10%
Adenomatous Polyposis Coli
10%
Chronic Drug Administration
10%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoembryonic Antigen
100%
Long Term Survival
100%
COX-2 Inhibitor
100%
Celecoxib
100%
Poxviridae
100%
Neoplasm
60%
Cyclooxygenase 2
50%
Intestine Tumor
20%
Familial Adenomatous Polyposis
20%
Transgenic Mouse
10%
Clinical Study
10%
Precancer
10%
Knockout Mouse
10%
Overall Survival
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Lipopolysaccharide
10%
Recombinant
10%
Tumor Model
10%
Concanavalin A
10%
Colon Polyposis
10%
Prostaglandin E2
10%
Eosinophilia
10%
Immunology and Microbiology
Poxviridae
100%
Long Term Survival
100%
Carcinoembryonic Antigen
100%
Cyclooxygenase
100%
Transgenics
20%
Tumor Volume
20%
T Cell
10%
Natural Killer Cell
10%
Antigen Specificity
10%
Splenic T Cell
10%
Knockout Mouse
10%
Breed
10%
Overall Survival
10%
Transgenic Mouse
10%
mRNA Expression Level
10%
Concanavalin A
10%
Host Immune Response
10%
Autoimmunity
10%
Prostaglandin E2
10%